CommercialMarch 1, 2024
Precertification list change notification — March 1, 2024
The following services will be added to precertification for the effective dates listed below.
To obtain precertification, providers can access Availity.com or call the Utilization Management department for Anthem using the number on the back of the member’s identification card. Service preapproval is based on member’s benefit plan/eligibility at the time the service is reviewed/approved.
Precertification can help avoid unnecessary charges or penalties by helping to ensure that the member's care is medically necessary and administered at an appropriate network facility and by a network provider.
Add to precertification
Criteria | Criteria description | Code | Effective date |
CG-MED-88 | Preimplantation Embryo Biopsy and Genetic Testing | 0254U | June 1, 2024 |
CG-MED-88 | Preimplantation Embryo Biopsy and Genetic Testing | 0396U | June 1, 2024 |
CG-OR-PR-08 | Microprocessor Controlled Lower Limb Prosthesis | L7510 | June 1, 2024 |
CG-OR-PR-08 | Microprocessor Controlled Lower Limb Prosthesis | L7520 | June 1, 2024 |
CG-SURG-61 | Cryosurgical, Radiofrequency, Microwave or Laser Ablation to Treat Solid Tumors Outside the Liver | 53850 | June 1, 2024 |
CG-SURG-61 | Cryosurgical, Radiofrequency, Microwave or Laser Ablation to Treat Solid Tumors Outside the Liver | 53852 | June 1, 2024 |
CG-SURG-61 | Cryosurgical, Radiofrequency, Microwave or Laser Ablation to Treat Solid Tumors Outside the Liver | C9751 | June 1, 2024 |
DME.00011 | Electrical Stimulation as a Treatment for Pain and Other Conditions: Surface and Percutaneous Devices | E0769 | June 1, 2024 |
DME.00041 | Ultrasonic Diathermy Devices | K1036 | June 1, 2024 |
DME.00043 | Neuromuscular Electrical Training for the Treatment of Obstructive Sleep Apnea or Snoring | E0490 | June 1, 2024 |
DME.00043 | Neuromuscular Electrical Training for the Treatment of Obstructive Sleep Apnea or Snoring | E0491 | June 1, 2024 |
Carelon Medical Benefits Management, Inc. Guidelines | Carelon Medical Benefits Management Genetic Testing Guideline | 0403U | June 1, 2024 |
Carelon Medical Benefits Management Guidelines | Carelon Medical Benefits Management Genetic Testing Guideline | 0411U | June 1, 2024 |
Carelon Medical Benefits Management Guidelines | Carelon Medical Benefits Management Genetic Testing Guideline | 0419U | June 1, 2024 |
Carelon Medical Benefits Management Guidelines | Carelon Medical Benefits Management Genetic Testing Guideline | 0262U | June 1, 2024 |
Carelon Medical Benefits Management Guidelines | Carelon Medical Benefits Management Genetic Testing Guideline | 0405U | June 1, 2024 |
Carelon Medical Benefits Management Guidelines | Carelon Medical Benefits Management Genetic Testing Guideline | 0409U | June 1, 2024 |
Carelon Medical Benefits Management Guidelines | Carelon Medical Benefits Management Genetic Testing Guideline | 0410U | June 1, 2024 |
Carelon Medical Benefits Management Guidelines | Carelon Medical Benefits Management Genetic Testing Guideline | 0413U | June 1, 2024 |
Carelon Medical Benefits Management Guidelines | Carelon Medical Benefits Management Genetic Testing Guideline | 0414U | June 1, 2024 |
Carelon Medical Benefits Management Guidelines | Carelon Medical Benefits Management Genetic Testing Guideline | 0415U | June 1, 2024 |
Carelon Medical Benefits Management Guidelines | Carelon Medical Benefits Management Genetic Testing Guideline | 0417U | June 1, 2024 |
LAB.00011 | Selected Protein Biomarker Algorithmic Assays | 0342U | June 1, 2024 |
LAB.00028 | Blood-based Biomarker Tests for Multiple Sclerosis | 0361U | June 1, 2024 |
LAB.00040 | Serum Biomarker Tests for Risk of Preeclampsia | 0390U | June 1, 2024 |
LAB.00041 | Machine Learning Derived Probability Score for Rapid Kidney Function Decline | 0407U | June 1, 2024 |
LAB.00046 | Testing for Biochemical Markers for Alzheimer’s Disease | 0412U | June 1, 2024 |
MED.00143 | Ingestible Devices for the Treatment of Constipation | A9268 | June 1, 2024 |
MED.00143 | Ingestible Devices for the Treatment of Constipation | A9269 | June 1, 2024 |
MED.00145 | Digital Therapy Devices for Treatment of Amblyopia | A9292 | June 1, 2024 |
SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | A2022 | June 1, 2024 |
SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | A2023 | June 1, 2024 |
SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | A2024 | June 1, 2024 |
SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | A2025 | June 1, 2024 |
SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | C1832 | June 1, 2024 |
SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Q4285 | June 1, 2024 |
SURG.00011 | Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Q4286 | June 1, 2024 |
SURG.00026 | Deep Brain, Cortical, and Cerebellar Stimulation | C1787 | June 1, 2024 |
SURG.00071 | Percutaneous and Endoscopic Spinal Surgery | C2614 | June 1, 2024 |
SURG.00144 | Occipital and Sphenopalatine Ganglion Nerve Block Therapy for the Treatment of Headache and Neuralgia | 64505 | June 1, 2024 |
TRANS.00009 | Portable Normothermic Organ Perfusion Systems | 0494T | June 1, 2024 |
TRANS.00009 | Portable Normothermic Organ Perfusion Systems | 0495T | June 1, 2024 |
TRANS.00009 | Portable Normothermic Organ Perfusion Systems | 0496T | June 1, 2024 |
Carelon Medical Benefits Management Guidelines | Carelon Medical Benefits Management Genetic Testing Guideline | 0088U | June 1, 2024 |
Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
CTBCBS-CM-049467-24-CPN49255
PUBLICATIONS: March 2024 Provider Newsletter
To view this article online:
Or scan this QR code with your phone